Rheumatic Arthritis Clinical Trial
Official title:
A Block-randomized, Double-blind, Placebo-controlled, Single-dose Escalating, Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers
A block-randomized, double-blind, placebo-controlled, single-dose escalating, phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics of YHB1411-2 in healthy male volunteers
First in human Study ;
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03685110 -
CoreHip - Post Market Clinical Follow-Up Study
|
||
Recruiting |
NCT04485325 -
Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients
|
Phase 4 | |
Not yet recruiting |
NCT02020668 -
Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient
|
Phase 2 | |
Recruiting |
NCT05007340 -
ILD-SARDs Registry and Biorepository
|
||
Completed |
NCT05291130 -
AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene
|
||
Active, not recruiting |
NCT04255966 -
Plasmafit® Revision Structan® Hip Endoprosthesis Cup
|